NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for LSBK yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Execute share buyback plan of up to 5% of shares | It has a clear plan to return cash to shareholders with a share buyback program. | Intact | No meaningful buybacks executed by end of 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a regional banking business with a recent record of strong financial performance, rather than a turnaround story. The long-term thesis is intact, but its risk label has risen from moderate to elevated.
The available valuation model describes LSBK as cheap versus peers, with high model confidence. The evidence gives little detail on what earnings expectations the market already assumes, so the expectations gap is unclear.
Near-term results show improving core banking income: net interest margin, the spread earned on lending and funding, rose to 4.17% in the third quarter of 2026, and nine-month net interest income increased from the prior year. Expense control is mixed: the efficiency ratio improved, but nine-month non-interest expense also rose.
The multi-year view hinges on continued margin and core banking growth, alongside disciplined expenses and prudent loan and deposit growth. Near term, a guidance cut or Fed rate cuts are listed as risks; continued earnings strength and higher guidance from sector peers are possible supports.
LSBK’s recent operating progress keeps the long-term thesis intact, while elevated risk and mixed expense control leave important execution and rate-related questions. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Lake Shore Bancorp keeps paying a steady dividend of $0.09 per share. |
| Intact |
| dividend per share falls below $0.09 in any quarter of 2026 |
Dividend per share: $0.09 per share FY2026-Q2; GAAP. Published target: >= $0.09 per share. The stored target says 2026-Q4; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 11, 20260.09 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
EPS grows to at least $0.97 in 2026 | The company shows stable earnings with EPS guidance near $0.97 for 2026. | Intact | EPS falls below $0.97 in FY26 | Diluted EPS: $0.29 per share FY2026-Q2; GAAP. Published target: >= $0.97 per share. Annual target cannot be compared with a quarterly or TTM observation. Aug 11, 20260.29 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.